Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015

Tyrosine Kinase Inhibitor (TKI) - B. Lum

A pre-clinical PKPD framework for biomarker led - R. Jones

A survey of new oncology drug approvals in the [...] - B. Lum

Dose escalation of tamoxifen in patients with low ... -C. Lee

Toxicity-adjusted dose (TAD) of sunitinib - H. Gurney

Dried blood spot sampling for therapeutic drug - D. De Wit

Drug-drug interactions in patients ... - R. van Leeuwen

Dose Individualization in H[...] - Courtney Fletches, PharmD

Everolimus exposure strongly related to dose [...]-D. De Wit

Marker of bevacizumab efficacy - C. Serdjebi

Microdosing as a pharmacokinetic assessment tool - W. Vaes

Modeling as a tool to individualize - Joga Gobburu, PhD, MBA

Obstacles to use dose optimization in an [...] - Rene Bruno, PhD

Optimal TDM and pharmacodynamics of mitotane - S. Ackland

Is cancer different - George Demetri, MD

Pharmacology as a tool to dose individualize [...] - Mark Ratain, MD

Population PKPD modeling of abexinostat-induced - S. Fouliard

Polymorphisms of nr1i2 and nr1i3 - L. Mbatchi

The use of PKPD modeling early in drug - Lena Friberg, PhD